These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9213861

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Acute effects of misoprostol on digital circulation in patients with Raynaud's phenomenon.
    Wise RA, Wigley F.
    J Rheumatol; 1994 Jan; 21(1):80-3. PubMed ID: 8151594
    [Abstract] [Full Text] [Related]

  • 4. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM, Kayser C, Pucinelli ML, Andrade LE.
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: a double blind crossover study.
    Finch MB, Dawson J, Johnston GD.
    Clin Rheumatol; 1986 Dec; 5(4):493-8. PubMed ID: 3816096
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vascular response of Raynaud's phenomenon to nifedipine or herbal medication (duhuo-tisheng tang with danggui-sini tang): a preliminary study.
    Wu YJ, Luo SF, Yang SH, Chen JY, Yu KH, See LC.
    Chang Gung Med J; 2008 Dec; 31(5):492-502. PubMed ID: 19097597
    [Abstract] [Full Text] [Related]

  • 9. Nifedipine in the treatment of idiopathic Raynaud's syndrome.
    Sarkozi J, Bookman AA, Mahon W, Ramsay C, Detsky AS, Keystone EC.
    J Rheumatol; 1986 Apr; 13(2):331-6. PubMed ID: 3723496
    [Abstract] [Full Text] [Related]

  • 10. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
    Gardinali M, Pozzi MR, Bernareggi M, Montani N, Allevi E, Catena L, Cugno M, Bottasso B, Stabilini R.
    J Rheumatol; 2001 Apr; 28(4):786-94. PubMed ID: 11327251
    [Abstract] [Full Text] [Related]

  • 11. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases.
    Kahan A, Weber S, Amor B, Menkes CJ, Hodara M, Degeorges M.
    Int Angiol; 1985 Apr; 4(2):221-3. PubMed ID: 3831143
    [Abstract] [Full Text] [Related]

  • 12. Slow release nifedipine in the treatment of Raynaud's phenomenon.
    Costantini A, Martelli E, Bavera P, Agus GB.
    Int Angiol; 1987 Apr; 6(4):359-63. PubMed ID: 3330116
    [Abstract] [Full Text] [Related]

  • 13. Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial.
    Dziadzio M, Denton CP, Smith R, Howell K, Blann A, Bowers E, Black CM.
    Arthritis Rheum; 1999 Dec; 42(12):2646-55. PubMed ID: 10616013
    [Abstract] [Full Text] [Related]

  • 14. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A, Abou-Raya S, Helmii M.
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
    Wise RA, Malamet R, Wigley FM.
    J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649
    [Abstract] [Full Text] [Related]

  • 17. [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon].
    Vayssairat M, Blaison N, Baudot N, Evenou P, Gilard M, Mathieu JF.
    J Mal Vasc; 1989 Apr; 14(4):299-302. PubMed ID: 2584886
    [Abstract] [Full Text] [Related]

  • 18. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.
    Riccio A, Del Puente A, Farinaro C, Scarpa R, Oriente P, Rocco P, Gioia M.
    Clin Ther; 1987 Apr; 9(2):232-7. PubMed ID: 3568066
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon.
    Bartolone S, Trifiletti A, De Nuzzo G, Scamardi R, Larosa D, Sottilotta G, Raffa A, Barbera N.
    Minerva Cardioangiol; 1999 May; 47(5):137-43. PubMed ID: 10479851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.